Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma

Published:2018-10-23 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Jacinto Alexandre Arthur^ORCID,Batalha Filho Eronides Salustiano,Viana Luciano de Souza,De Marchi Pedro,Capuzzo Renato de Castro,Gama Ricardo Ribeiro,Boldrini Junior Domingos,Santos Carlos Roberto,Pinto Gustavo Dix Junqueira,Dias Josiane Mourão,Canton Heloisa Pelisser,Carvalho Raiany,Radicchi Lucas Augusto,Bentzen Soren,Zubizarreta Eduardo,Carvalho Andre Lopes

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-018-4893-5.pdf

Reference33 articles.

1. Pignon JP, le Maitre A, Maillard E, Bourhis J, MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009;92(1):4–14.

2. Adelstein DJ, Li Y, Adams GL, Wagner H Jr, Kish JA, Ensley JF, Schuller DE, Forastiere AA. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003;21(1):92–8.

3. de Castro G Jr, Snitcovsky IM, Gebrim EM, Leitao GM, Nadalin W, Ferraz AR, Federico MH. High-dose cisplatin concurrent to conventionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2007;264(12):1475–82.

4. Forastiere AA. Cisplatin and radiotherapy in the management of locally advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 1993;27(2):465–70.

5. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349(22):2091–8.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase I/II study evaluating the feasibility and safety of delivering adjuvant hypofractionated radiotherapy in resected oral cavity cancers (HYPO-ART study);Oral Oncology Reports;2024-06

2. Latin American Consensus on the Treatment of Head and Neck Cancer;JCO Global Oncology;2024-04

3. HYPORT: Phase 1 Study of 3-Week Hypofractionated Postoperative Radiation Therapy for Head and Neck Squamous Cell Carcinoma;International Journal of Radiation Oncology*Biology*Physics;2024-01

4. Leave No Cancer Behind: The Conformal Hypofractionation Era and Head and Neck Cancer;International Journal of Radiation Oncology*Biology*Physics;2024-01

5. Other Head and Neck Sites;Hypofractionated and Stereotactic Radiation Therapy;2024